The Business of Mass-Tort Litigation

Key Takeaways

• The Business of Mass-Tort Litigation involves much more than filing lawsuits.
• Mass torts generally involve numerous individual claims connected to common alleged conduct or harm.
• MDL proceedings can coordinate related federal cases without automatically turning them into a class action.
• The U.S. Judicial Panel on Multidistrict Litigation reported 162 pending MDL dockets as of August 3, 2026.
• Product liability, pharmaceutical, environmental, data-security, antitrust, and other disputes can enter large-scale litigation.
• Client acquisition is only one part of the process.
• Strong screening and evidence collection are essential for managing large claimant populations.
• Litigation funding can provide capital while creating questions about transparency and conflicts.
• Advertising practices remain an active regulatory and legal issue.
• A settlement does not automatically mean every claimant receives the same recovery.
• Technology can improve large-scale case management, but professional oversight remains essential.
• For potential claimants, preserving records and obtaining advice about the specific case are more useful than relying on general advertising promises.

What Is Mass-Tort Litigation?

A mass tort generally arises when the same act, product, exposure, or business conduct allegedly causes harm to numerous people.

Unlike a single personal-injury lawsuit, there may be a large population of potential claimants. Each person’s circumstances can still matter independently.

The Legal Information Institute describes a mass tort as an act or omission that injures numerous people, with examples including pollution, contaminated groundwater, explosions, and other large-scale harmful events.

This is one reason the term mass tort should not automatically be treated as another name for a class action.

A mass tort may involve many separate lawsuits rather than one lawsuit representing everyone.

Mass Tort vs. Class Action

The distinction is important for anyone researching The Business of Mass-Tort Litigation.

In a class action, one or more representatives can sue on behalf of a defined class after the court determines that the legal requirements for class treatment have been satisfied. The result can bind class members under the applicable rules.

Mass-tort cases generally work differently.

An MDL itself is also not a class action. Federal judiciary materials specifically distinguish the two procedures and explain that an MDL can contain cases with different claims and injuries.

Why Do Mass Torts Develop?

Large-scale litigation can emerge from many different situations.

A company may manufacture a product that allegedly causes injuries. A pharmaceutical product may become the subject of claims involving alleged adverse effects. An industrial operation may expose communities to harmful substances.

Other disputes can involve consumer practices, data security, transportation accidents, environmental contamination, or emerging technologies.

The important point is that there is no single industry responsible for every mass tort.

The current MDL system reflects that variety. Recent federal proceedings have included data-security, antitrust, firefighter gear, patent, securities, social-media, pharmaceutical, and other disputes.

Common Types of Mass-Tort Claims

Product Liability Claims

These cases can involve allegations that a consumer product was defectively designed, manufactured improperly, or accompanied by inadequate warnings.

Potential disputes can involve vehicles, medical products, household goods, industrial equipment, and other products.

The exact legal theory depends on the facts and the jurisdiction.

Pharmaceutical and Medical Device Litigation

Drug and medical-device disputes have historically been an important part of mass litigation.

These cases can be particularly complex because proving an injury may require medical records, scientific evidence, expert analysis, and detailed information about the claimant’s exposure and medical history.

Current federal MDL records continue to show pharmaceutical and medical-device litigation among the proceedings handled through the system.

Environmental Claims

Environmental disputes can affect large populations when contamination or other alleged harmful conduct extends beyond one individual property.

Possible issues can include contaminated water, industrial pollution, chemical exposure, and alleged environmental damage.

The underlying facts can vary significantly from one claimant to another, which is one reason individual evidence remains important.

Data and Technology Claims

Mass litigation is also moving into newer areas.

Recent JPML proceedings include data-security breach litigation and disputes involving social-media platforms.

This shows how The Business of Mass-Tort Litigation is evolving alongside technology.

A dispute does not need to involve a traditional physical product to generate a large number of related claims.

How The Business of Mass-Tort Litigation Actually Works

There is much more happening behind a mass tort than filing lawsuits.

The process can involve legal research, claimant identification, medical review, evidence collection, expert analysis, advertising, technology, litigation finance, discovery, negotiations, and court administration.

Finding Potential Claimants

Law firms need to identify people who may have legitimate claims.

Depending on the jurisdiction and applicable professional rules, firms may use websites, search advertising, television, social media, referrals, informational campaigns, and other forms of outreach.

However, an advertisement response is only the beginning.

A potential claimant still needs to be evaluated against the requirements of the particular litigation.

Screening the Claim

Good case screening can be more valuable than simply generating a large number of leads.

Lawyers may need information about:

• The product or conduct involved
• When the exposure occurred
• Medical treatment
• The alleged injury
• Relevant records
• Purchases or product use
• Employment or location history
• Potential alternative causes
• Applicable deadlines

The exact requirements differ from one case to another.

A person who appears eligible from a short advertisement questionnaire may ultimately have a claim that does not satisfy the litigation’s criteria.

Building the Evidence

Once a case is accepted, evidence becomes central.

That can include medical records, product documents, photographs, employment records, purchase information, scientific material, communications, and other documentation.

Large litigation can generate enormous quantities of information, making organized case management essential.

The Role of Multidistrict Litigation

The MDL system is one of the most important mechanisms in U.S. mass litigation.

Congress created the Judicial Panel on Multidistrict Litigation through 28 U.S.C. § 1407. The seven-judge Panel decides whether qualifying federal civil actions should be transferred to one district for coordinated or consolidated pretrial proceedings.

The objective is practical.

Imagine hundreds of separate federal cases involving the same alleged product defect. Without coordination, lawyers and judges could repeatedly address overlapping discovery requests, scientific evidence, and pretrial motions.

Centralization can reduce that duplication.

Importantly, transferred cases generally remain individual cases. Cases that are not resolved during the centralized proceedings can ultimately return to their original federal districts for trial.

Why MDLs Matter So Much

The scale of the federal system illustrates why coordination matters.

The Judicial Panel reported 162 pending MDL dockets as of August 3, 2026.

Since its creation in 1968, the Panel says it has created more than 1,800 litigation dockets involving more than 1.3 million cases. Those figures cover a broad range of federal litigation and should not be interpreted as representing only personal-injury mass torts.

The numbers show the size of the machinery involved.

The Economics Behind Mass-Tort Cases

The Business of Mass-Tort Litigation has a unique financial structure.

A firm may have to spend significant resources long before a case produces a settlement or judgment.

Costs can include:

This creates a major difference from ordinary legal work.

The firm can invest money for years without knowing the outcome.

Contingency Fees and Financial Risk

Many personal-injury lawyers use contingency-fee arrangements, under which legal fees are generally tied to a recovery rather than being charged entirely as hourly fees.

The specific percentage, treatment of litigation expenses, and other terms depend on the agreement and applicable law.

For a mass tort, the financial exposure can become significant because the firm may be advancing resources across a large number of claims.

That makes careful case selection particularly important.

A database containing thousands of potential clients is not necessarily a valuable litigation portfolio.

The strength of the underlying claims matters far more.

Litigation Funding

Another part of the modern legal ecosystem is third-party litigation funding.

A funding company can provide capital to support litigation, with repayment and returns determined by the financing agreement.

Supporters argue that funding can help parties pursue expensive cases when they lack sufficient resources.

Critics, meanwhile, raise questions about transparency, conflicts of interest, control over litigation decisions, and the financial incentives created by outside capital.

These issues have become an active subject of legal and policy discussion.

For example, recent U.S. legislative proposals have focused on disclosure of third-party litigation funding in mass tort and class-action proceedings.

Because rules differ across jurisdictions, funding arrangements should not be treated as legally identical everywhere.

Advertising Has Become Part of the Industry

Modern legal marketing is another major element of The Business of Mass-Tort Litigation.

A firm may use television campaigns, search advertising, websites, social platforms, referral relationships, and other channels to reach people who may have relevant claims.

The scale of the legal advertising market can be substantial.

Recent reporting also shows that advertising practices remain subject to active legal disputes. In August 2026, Reuters reported that Morgan & Morgan sued the Florida Bar over restrictions concerning celebrity appearances in lawyer advertising.

The case illustrates a broader point: legal marketing is not simply a business decision.

Lawyers must also operate within professional and jurisdiction-specific advertising rules.

Why Claim Screening Matters

Mass-tort litigation can attract a very large number of inquiries.

That creates an obvious temptation to focus on volume.

But quantity alone does not establish legal merit.

A well-run operation needs to separate:

Interested person → Potential lead → Screened claimant → Accepted case → Supported claim

Those categories are not interchangeable.

Good screening can prevent firms from spending resources on claims that lack necessary evidence while allowing stronger cases to receive appropriate attention.

It can also make communication with clients more accurate.

Technology and Case Management

Technology has changed how firms manage large litigation inventories.

Instead of relying entirely on paper files and manual spreadsheets, firms can use digital systems to organize documents, deadlines, medical information, communications, and case status.

Artificial intelligence can also assist with certain administrative and document-heavy tasks.

Still, automation does not replace professional judgment.

In a mass tort, a small mistake repeated across thousands of records can create a much bigger problem than the same error would cause in a single case.

For that reason, technology works best when it supports careful human review.

The Importance of Bellwether Trials

One of the unusual features of many MDLs is the use of bellwether cases.

These are selected individual cases that may proceed toward trial before the broader litigation is resolved.

Their purpose is not to automatically decide every other claimant’s case.

Instead, the outcomes can provide information about evidence, legal arguments, trial risks, and potential settlement dynamics.

The Legal Information Institute explains that bellwether trials can help parties evaluate how juries may respond to the evidence and can influence decisions about whether to continue toward trial or pursue settlement.

What Happens When a Mass Tort Settles?

A settlement does not necessarily mean every claimant receives the same amount.

Individual claims may have different injuries, medical evidence, exposure histories, damages, and other relevant factors.

Settlement administration can therefore become a major operation of its own.

The process may involve eligibility review, documentation, claim evaluation, lien issues, attorney fees, expenses, and distribution.

The precise system depends on the litigation and the terms approved or adopted by the relevant court.

Advantages of Mass-Tort Litigation

Mass litigation can offer several practical advantages.

Shared Resources

Individuals may benefit from legal teams capable of investigating complicated scientific or technical issues.

Coordinated Discovery

MDL proceedings can reduce unnecessary duplication in federal cases.

Access to Experts

Large litigation can justify extensive expert investigation that may be difficult to finance through isolated individual cases.

Consistent Pretrial Management

Centralization can reduce the possibility of multiple federal courts repeatedly addressing the same preliminary issues.

Individual Representation

Unlike a certified class, individual mass-tort plaintiffs generally maintain their own claims and representation.

Challenges and Criticism

The same scale that makes mass litigation useful can also create serious problems.

Large Case Inventories

Thousands of files can become difficult to manage accurately.

Long Timelines

Complex discovery, expert disputes, motion practice, and settlement negotiations can take substantial time.

Advertising Pressure

Aggressive marketing may create unrealistic expectations if advertisements simplify the litigation.

Funding Conflicts

Outside financing can raise questions about who benefits financially and who controls important decisions.

Uneven Claim Quality

Not every claimant will have the same evidence or level of injury.

Administrative Complexity

A settlement involving a large population can require sophisticated systems to evaluate and distribute claims.

What Makes a Strong Mass-Tort Operation?

The strongest legal operation is not necessarily the one with the largest advertising budget.

It is the one that can connect responsible client acquisition with rigorous legal screening, evidence preservation, efficient case management, experienced counsel, and transparent communication.

That requires discipline.

A firm may receive thousands of inquiries, yet only a portion may ultimately satisfy the requirements of a particular proceeding.

Consequently, the real value lies in developing legitimate claims rather than simply accumulating names.

Common Mistakes People Make

Assuming an Advertisement Means a Case Is Guaranteed

Legal advertisements generally seek potential clients. They do not establish that someone will win compensation.

Confusing an MDL With a Class Action

The procedures are different, and individual MDL claims generally retain their separate identity.

Ignoring Medical Documentation

In injury litigation, records can be central to evaluating the nature and timing of an alleged injury.

Waiting Too Long

Legal deadlines vary by jurisdiction and claim type. Anyone considering legal action should obtain advice about applicable deadlines rather than assuming there is unlimited time.

Focusing Only on the Settlement Amount

A headline settlement figure does not tell an individual claimant exactly what they will receive.

The actual process can depend on eligibility, evidence, allocation rules, fees, expenses, and other factors.

A Simple Guide for Potential Claimants

If you believe you may have been harmed by a product, drug, company practice, or environmental exposure, begin by preserving relevant information.

Keep medical records, receipts, product information, photographs, communications, and other documents that may establish what happened.

Then speak with a qualified lawyer who can evaluate your specific circumstances.

Avoid relying solely on an advertisement’s headline promise.

Instead, ask practical questions about eligibility, fees, expenses, the litigation’s current stage, potential risks, and how your individual claim will be handled.

Conclusion

The Business of Mass-Tort Litigation sits at the intersection of law, business, technology, finance, and individual rights.

A large-scale litigation may begin with something surprisingly simple: many people experiencing similar harm. From there, however, the process can become highly sophisticated.

Law firms must identify potential claimants, screen cases, collect evidence, manage large databases, work with experts, finance years of litigation, and comply with professional rules. Courts, meanwhile, have to manage proceedings that can involve enormous numbers of individual cases.

The MDL system provides one important method for coordinating related federal litigation. Current federal records show that this remains a significant part of the U.S. court system, while newer disputes demonstrate that mass litigation continues to expand into areas shaped by technology and changing business practices.

For individuals, the most important lesson is simple: being contacted by a mass-tort advertisement does not automatically mean that a claim will succeed.

A legitimate case still depends on facts, evidence, applicable law, eligibility requirements, and the circumstances of the individual claimant.

That is why understanding The Business of Mass-Tort Litigation matters. Behind every large case are real people with different experiences, different evidence, and different legal circumstances. The challenge is building a system large enough to handle thousands of claims while still treating each person’s case with the attention it deserves

Frequently Asked Questions

What does The Business of Mass-Tort Litigation mean?

It describes the legal and commercial ecosystem surrounding large numbers of related individual claims.

It can include lawyers, clients, experts, technology companies, marketing organizations, litigation funders, administrators, and courts.

Is every mass tort an MDL?

No.

A mass tort describes a large group of related injury claims. An MDL is a federal procedural mechanism that can coordinate qualifying cases involving common factual questions.

Is an MDL the same as a class action?

No.

A class action requires certification under applicable class-action rules. MDL proceedings coordinate individual federal cases for pretrial purposes and do not automatically turn those cases into one class action.

Do mass-tort plaintiffs lose their individual claims?

Generally, an MDL does not erase the individual nature of the underlying cases.The cases can be coordinated for pretrial proceedings while retaining their individual identities.

What kinds of cases can become mass torts?

Potential examples include product liability, pharmaceutical and medical-device claims, environmental disputes, data-security litigation, and other situations involving numerous related claims.

How do law firms find mass-tort clients?

Depending on applicable rules, firms may use advertising, websites, search marketing, referrals, social media, and other lawful outreach methods.

Does responding to a mass-tort advertisement mean someone is eligible?

No. Eligibility must be evaluated against the specific facts and requirements of the relevant litigation.

Why can mass-tort cases take so long?

Large proceedings may require extensive discovery, expert analysis, motions, individual claim evaluation, bellwether trials, negotiations, and settlement administration.

Can a mass-tort settlement pay everyone equally?

Not necessarily. Individual claims can differ significantly, and the settlement structure determines how eligible claims are evaluated and paid.